News
Colorectal cancer incidence doubled in younger adults
- Author:
- Roxanne Nelson, RN, BSN
Diagnoses in people younger than 55 years doubled from 1995 to 2019.
News
Prostate cancer subgroup may benefit from intensified therapy
- Author:
- Roxanne Nelson, RN, BSN
A new trial explored whether for patients with prostate cancer who have unfavorable features and a detectable PSA following a radical...
News
Talazoparib add-on improves outcomes in metastatic prostate cancer
- Author:
- Roxanne Nelson, RN, BSN
As determined on the basis of imaging, PFS was 37% better for talazoparib plus enzalutamide than for enzalutamide monotherapy.
News
Adjuvant nivolumab as standard of care in resected bladder cancer
- Author:
- Roxanne Nelson, RN, BSN
Compared with placebo, nivolumab improves disease-free survival, nonurothelial tract recurrence-free survival, and distant metastasis-free...
News
Rucaparib benefit in BRCA+ prostate cancer confirmed
- Author:
- Roxanne Nelson, RN, BSN
New study finding provides evidence of clinical benefit for an indication for rucaparib that was granted an accelerated approval in May 2020.
News
Oncologist files whistleblower lawsuit against Roswell Park
- Author:
- Roxanne Nelson, RN, BSN
“I am speaking out because time and again female doctors are unable to deliver on the promise of their medical training because of discrimination...
News
New ‘reference regimen’ in metastatic pancreatic cancer?
- Author:
- Roxanne Nelson, RN, BSN
NALIRIFOX regimen can be considered new reference regimen for first-line pancreatic cancer treatment, a researcher reports at ASCO GI.
News
SUNLIGHT shows new standard of care in refractory metastatic CRC
- Author:
- Roxanne Nelson, RN, BSN
Adding bevacizumab to trifluridine/tipiracil significantly improved survival, researchers report at ASCO GI.
News
Adding SBRT to sorafenib boosts survival in liver cancer
- Author:
- Roxanne Nelson, RN, BSN
The use of SBRT in this setting improved both overall survival and progression-free survival, researchers reported at ASCO GI.
News
Regorafenib: New option for advanced gastroesophageal cancer?
- Author:
- Roxanne Nelson, RN, BSN
Regorafenib significantly improves survival, compared with placebo, in patients with refractory AGOC, researchers report at ASCO GI.
News
Longest overall survival ever seen in advanced gastric cancer
- Author:
- Roxanne Nelson, RN, BSN
“Zolbetuximab plus mFOLFOX6 is a new potential standard treatment for these patients.”
News
‘Low-value’ prostate cancer screening prevalent in primary care
- Author:
- Roxanne Nelson, RN, BSN
A new study shows that testing for prostate-specific antigen and also digital rectal examinations are both carried out frequently in older men.
News
Oral minoxidil improves anticancer treatment–induced alopecia in women with breast cancer
- Author:
- Roxanne Nelson, RN, BSN
Oral minoxidil has been receiving increased attention as an adjunctive therapy for hair loss, particularly for women.
News
New test that detects 14 cancers focuses on sugars, not DNA
- Author:
- Roxanne Nelson, RN, BSN
“The main advantage of glycosaminoglycans appears to be that they change in the blood and urine at the earliest stages of cancer.”
News
Subset of patients with melanoma have very low mortality risk
- Author:
- Roxanne Nelson, RN, BSN
The authors were interested in identifying lesions that are currently diagnosed as melanoma but might lack the capacity for metastasis.